National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Prev Med. 2020 May;134:106051. doi: 10.1016/j.ypmed.2020.106051. Epub 2020 Mar 7.
This study examined national trends in self-directed violence in the context of changes in opioid use and depression to better inform prevention measures. Using 2000-2015 National Inpatient Sample (NIS) data, we identified 625,064 hospitalizations for self-directed violence among persons aged ≥10 years in the United States. Based on whether co-listing opioid related diagnosis and depression, we categorized hospitalizations for self-directed violence into four comorbid categories as 1) related to opioids alone; 2) related to depression alone; 3) related to both opioids and depression; and 4) related to neither opioids nor depression. Census population estimates served as the denominator for calculating hospitalization rates for self-directed violence. Hospitalization rates for self-directed violence related to opioids doubled from 5.1 per 100,000 persons in 2000 to 11.0 in 2015. The rate of increase was highest for self-directed violence related to both opioids and depression, which increased 9.4% annually during 2000-2011 and then decreased 4.3% annually during 2011-2015. Hospitalizations for self-directed violence related to depression alone remained the predominant category, accounting for approximately 60% of hospitalizations for self-directed violence; the rates among females aged 10-24 years were the highest among all subgroups, and rose 7.8% annually since 2011 reaching 93.2 per 100,000 persons in 2015. These findings highlight the importance of assessing the risk for self-directed violence among patients misusing opioids and the importance of treating opioid use disorder and depression, particularly when they co-occur. Prevention and treatment of depression is especially important for young females.
本研究考察了在阿片类药物使用和抑郁变化背景下的自我伤害行为的全国趋势,以便更好地为预防措施提供信息。使用 2000-2015 年国家住院患者样本(NIS)数据,我们确定了美国 625064 例年龄≥10 岁的自我伤害行为住院患者。根据是否共同列出阿片类药物相关诊断和抑郁,我们将自我伤害行为的住院情况分为四个共病类别:1)仅与阿片类药物有关;2)仅与抑郁有关;3)与阿片类药物和抑郁都有关;4)与阿片类药物和抑郁都无关。人口普查估计数作为计算自我伤害行为住院率的分母。与阿片类药物有关的自我伤害行为的住院率从 2000 年的每 10 万人 5.1 例增加到 2015 年的 11.0 例。与阿片类药物和抑郁都有关的自我伤害行为的增长率最高,在 2000-2011 年期间每年增加 9.4%,然后在 2011-2015 年期间每年减少 4.3%。仅与抑郁有关的自我伤害行为仍然是主要类别,占自我伤害行为住院的约 60%;10-24 岁女性亚组的比率在所有亚组中最高,自 2011 年以来每年增长 7.8%,达到 2015 年的每 10 万人 93.2 例。这些发现强调了评估阿片类药物滥用患者自我伤害风险的重要性,以及治疗阿片类药物使用障碍和抑郁的重要性,特别是当它们同时存在时。预防和治疗抑郁对于年轻女性尤为重要。